title: [Incretins have changed and continue to change treatment strategy for type 2 diabetes].
abstract: Incretins are a novel class of drugs indicated for therapeutic intervention in patients with type 2 diabetes. They provide effective and safe therapy. Their advantages include low risk of hypoglycaemia and positive effect on body weight. Literature published so far consistently evidences reduced cardiovascular risk. If long-term prospective studies confirm such an effect, incretin therapy will, together with metformin, become the first line treatment for type 2 diabetes.
authors.affiliation: Interní klinika 2. lékarské fakulty UK a FN Motol Praha. milan.kvapil@lfmotol.cuni.cz
authors.forename: M
authors.initials: M
authors.lastname: Kvapil
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D054795:Incretins / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D054795:Incretins